School of Medicine
Showing 301-320 of 5,052 Results
-
Philip Beachy
The Ernest and Amelia Gallo Professor, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsFunction of Hedgehog proteins and other extracellular signals in morphogenesis (pattern formation), in injury repair and regeneration (pattern maintenance). We study how the distribution of such signals is regulated in tissues, how cells perceive and respond to distinct concentrations of signals, and how such signaling pathways arose in evolution. We also study the normal roles of such signals in stem-cell physiology and their abnormal roles in the formation and expansion of cancer stem cells.
-
Dr. Gregory Bean
Associate Professor of Pathology
BioDr. Bean is an Associate Professor who specializes in breast pathology. His research interests include molecular characterization of breast cancer subtypes and precursors. He is also involved with the training of residents and fellows on the breast service.
-
Christopher Beaulieu M.D., Ph.D.
Professor of Radiology (Musculoskeletal Imaging)
On Partial Leave from 01/05/2026 To 06/26/2026Current Research and Scholarly InterestsInformatics and image processing techniques that provide infrastructure for diagnosis in musculoskeletal imaging. Decision support for improving accuracy of bone tumor diagnosis. Improved methods for MRI in the musculoskeletal system.
-
Nataly Beck, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioAs co-founder and co-director of ALMA Clinic, Dr. Nataly Beck is a psychiatrist who is passionate about providing compassionate, evidence-based, culturally sensitive, and language-concordant care to patients, especially including those from the Hispanic or Latin-American community. Originally from Lima, Peru, she immigrated to the US with her family at a young age. After attending the University of Tennessee-Knoxville, she attended Yale School of Medicine and then completed her psychiatry residency at Vanderbilt University Medical Center. As a Clinical Assistant Professor at Stanford, she co-founded ALMA Clinic (formerly known as La Clínica Latina) in 2021 and has been inspired to see the impact that the clinic has had on many Hispanic and Latin-American patients. Dr. Beck is honored to have the opportunity to co-lead the team of providers, graduate and undergraduate students, and others at Stanford Medicine that have the united goal of providing excellent care to patients as well as to advance mental health care in the Hispanic and Latin-American community.
Como cofundadora y codirectora de la Clínica ALMA, la Dra. Nataly Beck es una psiquiatra apasionada por brindar atención compasiva, basada en la evidencia, culturalmente sensible y en el idioma del paciente, especialmente a aquellos de la comunidad hispana o latinoamericana. Originaria de Lima, Perú, emigró a Estados Unidos con su familia a una edad temprana. Tras estudiar en la Universidad de Tennessee-Knoxville, cursó sus estudios de medicina en la Facultad de Medicina de Yale y completó su residencia en psiquiatría en el Centro Médico de la Universidad de Vanderbilt. Como profesora clínica adjunta en Stanford, cofundó la Clínica ALMA (anteriormente conocida como La Clínica Latina) en 2021 y se siente inspirada al ver el impacto que la clínica ha tenido en muchos pacientes hispanos y latinoamericanos. La Dra. Beck se siente honrada de tener la oportunidad de codirigir el equipo de profesionales, estudiantes de posgrado y pregrado, y demás personal de Stanford Medicine, quienes comparten el objetivo de brindar una atención excelente a los pacientes y de promover la salud mental en la comunidad hispana y latinoamericana. -
Hans-Christoph Becker, MD, FSABI, FSCCT
Clinical Professor, Radiology
Current Research and Scholarly InterestsMyocardial bridges (MB) with associated upfront atherosclerotic lesions are common findings on coronary computed tomography angiography (CTA). Abnormal septal wall motion in exercise echocardiography (EE) may to be associated with MB. Intravascular ultrasound (IVUS) is considered the gold standard for the detection of MB. We investigate whether CTA is comparable to IVUS for the assessment of MB and upstream plaques in symptomatic patients with suspicion for MB raised by EE.
-
Joseph Becker
Clinical Associate Professor, Emergency Medicine
BioDr. Joseph Becker is an Associate Professor of Emergency Medicine at Stanford University School
of Medicine. He received his Doctorate of Medicine from the University of California, San
Francisco in 2003. Subsequent to this, Dr . Becker completed an internship in Aerospace
Medicine at the National Aeronautics and Space Administration (NASA) before completing specialty
training in Emergency Medicine at Yale University. In 2010 Dr Becker completed a fellowship in
Global Emergency Medicine at Stanford University School of Medicine. Dr. Becker has served as
Laboratory Officer and Associate Research Scientist at the Mailman School of Public Health at
Columbia University and holds the title of Senior Lecturer and Visiting Associate Professor at the
University of Rwanda where he has worked consistently for nearly twenty years assisting in the
creation and development of the Emergency and Critical Care Residency program. He currently
holds the title of Head of Department and Curriculum for Emergency Medicine for the
University of Global Health Equity (UGHE) also in Rwanda. Dr. Becker is a Lieutenant Colonel in the United States Air
Force/California Air National Guard and currently serves as an Aerospace and
Operational Medicine specialist/Flight Surgeon with the 129th Rescue Wing in Mountain View, California. -
Laren Becker
Assistant Professor of Medicine (Gastroenterology)
BioI am a physician-scientist in the Division of Gastroenterology at Stanford University. My clinical and research interest has been in neurogastroenterology. Specifically, my research has been exploring the interplay between immune cells and the enteric nervous system, and evaluating how perturbations of this interaction as a result of aging disrupts gastrointestinal neuromuscular function. Ultimately, my hope is that insights from this research provide novel therapies for treating patients with motility disorders like constipation and irritable bowel syndrome.
-
Harmeet Bedi
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Harmeet Bedi is the Director of Interventional Pulmonology & Bronchoscopy at Stanford University. His expertise is in minimally invasive techniques used in the diagnosis and treatment of various airway and lung diseases such as lung cancer, benign & malignant airway obstruction, and pleural diseases. He specializes in rigid & flexible bronchoscopy, robotic bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS), and various pleural procedures. He also specializes in a variety of tumor ablative therapies including laser therapy, electrocautery, argon plasma coagulation (APC), brachytherapy, and cryotherapy.
He founded the cone-beam computed tomography (CBCT) - guided bronchoscopy program at Stanford in 2019. CBCT-guided bronchoscopy is a novel and cutting-edge technique which combines bronchoscopy with CT imaging, allowing for improved localization and diagnosis of peripheral lung nodules. Additionally, CBCT-guided bronchoscopy will allow for numerous potential cancer therapies that are currently under development.
Dr. Bedi is a principal investigator and co-investigator on multiple clinical trials related to bronchoscopy, thoracic imaging, pulmonary nodules, and lung cancer. Specifically, he has multiple research interests within the realm of bronchoscopic device innovation and CBCT-guided bronchoscopy. -
Andrew Beel
Instructor, Structural Biology
BioAndrew Beel received an M.D. and a Ph.D. in Biophysics from Stanford, where he studied the structure and condensation of the eukaryotic chromosome under the supervision of Roger Kornberg. He started his independent research program in late 2022 after receiving an Early Independence Award from the Office of the Director of the National Institutes of Health. His group is broadly interested in mesoscale biological organization and the physical underpinnings thereof, with a current emphasis on the axial core of the metaphase chromosome. The Beel lab is actively recruiting new members at all stages of training; interested parties are encouraged to apply (please direct inquiries to beelaj@stanford.edu).
-
Barry Behr, Ph.D., H.C.L.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility), Emeritus
Current Research and Scholarly InterestsDevelopment of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility. Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.
-
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
-
Gill Bejerano
Professor of Developmental Biology, of Computer Science and of Pediatrics (Genetics)
Current Research and Scholarly Interests1. Automating monogenic patient diagnosis.
2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
3. The logic of human gene regulation.
4. The reasons for sequence ultraconservation.
5. Cryptogenomics to bridge medical silos.
6. Cryptogenetics to debate social injustice.
7. Managing patient risk using machine learning.
8. Understanding the flow of money in the US healthcare system. -
Ruth Belay, MD
Clinical Assistant Professor, Urology
BioDr. Belay is a fellowship-trained urologic oncologist with the Stanford Health Care Urologic Cancer Program. She is also a clinical instructor in the Department of Urology at Stanford University School of Medicine.
Dr. Belay specializes in diagnosing and treating disorders of the urinary tract, including kidney cancer, enlarged prostate, ureteral stones, and blood in the urine. She also treats all types of genitourinary cancers. She is skilled in the use of multiple imaging and treatment modalities, including cystoscopy, endourology, laparoscopy, laser therapy and surgery, ultrasound, urodynamic testing, ureteroscopy, and robotic surgery. Dr. Belay works closely with her patients to provide a comprehensive evaluation and care plan.
Her research interests include pain control during robot-assisted prostatectomy (prostate removal) and determining the best types of guidewires for bypassing stones in the ureter. She has also studied the effects of caffeine on postmenopausal women with overactive bladder symptoms
Dr. Belay is involved with the Stanford Medicine Center for Improvement, the goal of which is to inspire and accelerate the delivery of consistent, excellent care across Stanford Medicine. She is also passionate about sharing her knowledge of urology with medical students, having taught and mentored several residents and post-doctoral fellows.
Dr. Belay’s research has appeared in several peer-reviewed journals, including Urology Practice, Journal of Endourology, and Journal of Women’s Health. She has presented her work both nationally and internationally at meetings and conferences of professional organizations including the American Urological Association (AUA); Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction; and World Congress of Endourology.
Dr. Belay is a member of the AUA and Society of Urologic Oncology.
